Mitsubishi UFJ Asset Management UK Ltd. Purchases 2,500 Shares of Intuitive Surgical, Inc. $ISRG

Mitsubishi UFJ Asset Management UK Ltd. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 138.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,300 shares of the medical equipment provider’s stock after buying an additional 2,500 shares during the quarter. Intuitive Surgical accounts for 0.9% of Mitsubishi UFJ Asset Management UK Ltd.’s portfolio, making the stock its 29th largest position. Mitsubishi UFJ Asset Management UK Ltd.’s holdings in Intuitive Surgical were worth $1,923,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Rossmore Private Capital lifted its holdings in shares of Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after acquiring an additional 20 shares during the last quarter. Activest Wealth Management raised its position in Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares during the period. Vertex Planning Partners LLC raised its position in Intuitive Surgical by 2.3% in the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after purchasing an additional 21 shares during the period. Accredited Investors Inc. lifted its stake in Intuitive Surgical by 2.0% in the third quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock worth $474,000 after purchasing an additional 21 shares during the last quarter. Finally, SPC Financial Inc. lifted its stake in Intuitive Surgical by 1.3% in the third quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider’s stock worth $722,000 after purchasing an additional 21 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 464 shares of the stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the transaction, the senior vice president directly owned 131 shares of the company’s stock, valued at $71,852.19. This represents a 77.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gary S. Guthart sold 2,800 shares of the firm’s stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $531.52, for a total transaction of $1,488,256.00. Following the completion of the sale, the director owned 15,720 shares of the company’s stock, valued at $8,355,494.40. This trade represents a 15.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 56,189 shares of company stock valued at $30,785,441. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of several analyst reports. Barclays set a $712.00 price objective on Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday, January 26th. Truist Financial raised their price target on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research report on Thursday, December 18th. Daiwa Securities Group lifted their price target on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Royal Bank Of Canada boosted their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Finally, Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Stock Performance

ISRG opened at $504.05 on Friday. The stock has a market capitalization of $179.00 billion, a PE ratio of 63.88, a price-to-earnings-growth ratio of 3.87 and a beta of 1.65. The stock’s 50 day moving average price is $535.88 and its 200-day moving average price is $510.51. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $607.35.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm’s revenue was up 18.8% on a year-over-year basis. During the same quarter last year, the firm posted $2.21 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.